COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Posted by  Written by Dezan Shira & Associates

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on June 7, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

  • Brunei recorded two new cases on June 1, taking the total to 242 cases amid three deaths.
  • Brunei reported one new case on May 31, taking the total to 242 cases amid three deaths.
  • Brunei saw one new case on May 28, bringing the total to 241 cases amid three deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

  • Cambodia saw 589 new cases and three deaths on June 7, taking the totals to 34,833 cases and 266 deaths.
  • Cambodia reported 631 new cases and 11 deaths on June 6, bringing the tallies to 34,244 cases and 263 deaths.
  • Cambodia saw 538 new cases and 10 deaths on June 5, taking the totals to 33,613 cases and 252 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 268 million and price sensitivity at Sinovac’s estimated costs at 200,000 rupiah (US$20) a dose. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.  Australia has stated it will also provide financial support to solve these issues.  

  • Indonesia recorded 6.993 new cases and 191 deaths on June 7, taking the tallies to 1,863,031 cases and 51,803 deaths.
  • Indonesia reported 5,832 new cases and 163 deaths on June 6, bringing the totals to 1,856,038 cases and 51,612 deaths.
  • Indonesia saw 6,594 new cases and 153 deaths on June 5, taking the tallies to 1,850,206 cases and 51,449 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

  • Laos reported six new cases on June 6, bringing the total to 1,963 cases amid three deaths.
  • Laos recorded five new cases on June 5, taking the total to 1,957 cases amid three deaths.
  • Laos reported nine new cases on June 3, bringing the total to 1,943 cases amid three deaths.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

  • Malaysia reported 5,271 new cases and 82 deaths on June 7, taking the tallies to 622,086 cases and 3,460 deaths.
  • Malaysia saw 6,241 new cases and 87 deaths on June 6, bringing the totals to 616,815 cases and 3,378 deaths.
  • Malaysia recorded 7,452 new cases and 109 deaths on June 5, bringing the tallies to 610,574 cases and 3,291 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

  • Myanmar reported 64 new cases and two deaths on June 6, taking the tallies to 144,317 cases and 3,225 deaths.
  • Myanmar recorded 96 new cases and two deaths on June 5, bringing the total to 144,253 cases and 3,223 deaths.
  • Myanmar saw 212 new cases on June 4, bringing the totals to 144,157 cases amid 3,221 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

  • The Philippines recorded 6,539 new cases and 71 deaths on June 7, taking the tallies to 1,276,004 cases and 21,969 deaths.
  • The Philippines reported 7,228 new cases and 166 deaths on June 6, bringing the totals to 1,269,478 cases and 21,898 deaths.
  • The Philippines reported 6,955 new cases and 195 deaths on June 5, taking the tallies to 1,262,273 cases and 21,732 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

  • Singapore reported 14 new cases on June 7, bringing the total to 62,210 cases amid 33 deaths.
  • Singapore saw 20 new cases on June 6, taking the total to 62,196 cases amid 33 deaths.
  • Singapore reported 18 new cases on June 5, taking the total to 62,176 cases amid 33 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

  • Thailand saw 2,419 new cases and 33 deaths on June 7, bringing the tallies to 179,886 cases and 1,269 deaths.
  • Thailand reported 2,671 new cases and 23 deaths on June 6, taking the totals to 177,467 cases and 1,236 deaths.
  • Thailand reported 2,817 new cases and 36 deaths on June 5, bringing the tallies to 174,796 cases and 1,213 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

  • As of June 7, 2021, Vietnam’s Ministry of Health confirmed a total of 8,883 cases of COVID-19. However, 3,368 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 53 deaths due to the pandemic. The latest community transmission cases have been reported from Bac Giang, Bac Ninh, Ho Chi Minh City, and Ha Nam.

  • Vietnam reported 141 new cases on June 6, bringing the total to 8,682 cases amid 53 deaths.
  • Vietnam saw 171 new cases and one death on June 5, bringing the totals to 8,458 cases and 53 deaths.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either. 

  • Afghanistan has 80,744 cases and 3,195 deaths as of June 6.
  • As of June 5, Afghanistan has 79,224 cases and 3,145 deaths.
  • Afghanistan has 77,938 cases and 3,097 deaths as of June 4.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

  • As of June 7, Bangladesh has 812,960 cases and 12,869 deaths.
  • As of June 6, Bangladesh has 810,990 cases and 12,839 deaths.
  • Bangladesh has 809,314 cases and 12,801 deaths as of June 5.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

  • Bahrain has 251,078 cases and 1,119 deaths as of June 6.
  • As of June 5, Bahrain has 249,582 cases and 1,091 deaths.
  • Bahrain has 248,150 cases and 1,069 deaths as of June 4.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

  • China recorded 19 new cases on June 7, taking the total to 91,267.
  • China saw 30 new cases on June 6, taking the total to 91,248.
  • China recorded 24 new cases on June 5, bringing the total to 91,218.

East Timor

East Timor is receiving assistance from the Gavi Institute.  

  • As of June 6, East Timor has 7,740 cases and 17 deaths.
  • East Timor has 7,659 cases and 17 deaths as of June 5.
  • As of June 4, East Timor has 7,511 cases and 17 deaths.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

  • Hong Kong has 11,866 cases and 210 deaths as of June 7.
  • As of June 6, Hong Kong has 11,859 cases and 210 deaths.
  • Hong Kong has 11,852 cases and 210 deaths as of June 5.

India

For a complete overview of India’s vaccine availability please go here.

  • India has 28,909,604 cases and 349,229 deaths as of June 6.
  • As of June 5, India has 28,808,372 cases and 346,784 deaths.
  • Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

  • Iran has 2,971,270 cases and 81,183 deaths as of June 7.
  • Iran has 2,966,363 cases and 81,063 deaths as of June 6.
  • As of June 5, Iran has 2,960,751 cases and 80,941 deaths.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

  • Iraq has 1,224,992 cases and 16,538 deaths as of June 6.
  • As of June 5, Iraq has 1,221,678 cases and 16,518 deaths.
  • Iraq has 1,218,524 cases and 16,488 deaths as of June 4.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

  • Japan has 760,323 cases and 13,523 deaths as of June 6.
  • As of June 5, Japan has 757,663 cases and 13,449 deaths.
  • Japan has 755,065 cases and 13,364 deaths as of June 4.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

  • Jordan has 739,847 cases and 9,530 deaths as of June 6.
  • As of June 5, Jordan has 739,319 cases and 9,516 deaths.
  • Jordan has 739,015 cases and 9,509 deaths as of June 4.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

  • Kazakhstan has 395,064 cases and 4,076 deaths as of June 7.
  • Kazakhstan has 394,075 cases and 4,042 deaths as of June 6.
  • As of June 5, Kazakhstan has 392,884 cases and 4,042 deaths.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

  • Kuwait has 317,197 cases and 1,795 deaths as of June 6.
  • As of June 5, Kuwait has 315,900 cases and 1,794 deaths.
  • Kuwait has 314,569 cases and 1,787 deaths as of June 4.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

  • Kyrgyzstan has 107,335 cases and 1,852 deaths as of June 7.
  • As of June 6, Kyrgyzstan has 106,973 cases and 1,847 deaths.
  • Kyrgyzstan has 106,636 cases and 1,842 deaths as of June 5.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

  • Lebanon has 541,557 cases and 7,763 deaths as of June 6.
  • As of June 5, Lebanon has 541,423 cases and 7,758 deaths.
  • Lebanon has 541,232 cases and 7,752 deaths as of June 4.

Macao

Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.   

  • As of May 28, Macao has 51 cases.
  • Macao has 50 cases as of May 20.
  • As of April 10, Macao has 49 cases.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

  • The Maldives has 67,950 cases and 185 deaths as of June 6.
  • As of June 5, the Maldives has 67,538 cases and 182 deaths.
  • The Maldives has 66,948 cases and 177 deaths as of June 4.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

  • As of June 7, Mongolia has 66,443 cases and 313 deaths.
  • Mongolia has 65,266 cases and 311 deaths as of June 6.
  • Mongolia has 63,978 cases and 307 deaths as of June 5.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

  • As of June 7, Nepal has 591,494 cases and 7,990 deaths.
  • Nepal has 588,124 cases and 7,898 deaths as of June 6.
  • Nepal has 585,100 cases and 7,799 deaths as of June 5.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

  • North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

  • As of June 7, Oman has 225,095 cases and 2,424 deaths.
  • Oman has 223,879 cases and 2,413 deaths as of June 6.
  • Oman has 220,702 cases and 2,385 deaths as of June 3.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

  • As of June 7, Pakistan has 933,630 cases and 21,323 deaths.
  • Pakistan has 932,140 cases and 21,265 deaths as of June 6.
  • Pakistan has 930,511 cases and 21,189 deaths as of June 5.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

  • Palestine has 310,026 cases and 3,517 deaths as of June 6.
  • As of June 5, Palestine has 309,853 cases and 3,516 deaths.
  • Palestine has 309,644 cases and 3,511 deaths as of June 4.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

  • Qatar has 218,627 cases and 569 deaths as of June 6.
  • Qatar has 218,455 cases and 566 deaths as of June 5.
  • Qatar has 218,263 cases and 565 deaths as of June 4.

Russia

A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

  • Russia has 5,135,866 cases and 124,117 deaths as of June 7.
  • As of June 6, Russia has 5,126,437 cases and 123,787 deaths.
  • Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

  • As of June 7, Saudi Arabia has 458,707 cases and 7,471 deaths.
  • As of June 6, Saudi Arabia has 457,546 cases and 7,456 deaths.
  • Saudi Arabia has 456,562 cases and 7,440 deaths as of June 5.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

  • South Korea has 144,637 cases and 1,974 deaths as of June 7.
  • As of June 6, South Korea has 144,152 cases and 1,973 deaths.
  • South Korea has 143,596 cases and 1,971 deaths as of June 5.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

  • Sri Lanka has 205,333 cases and 1,696 deaths as of June 6.
  • As of June 5, Sri Lanka has 202,357 cases and 1,656 deaths.
  • Sri Lanka has 199,254 cases and 1,656 deaths as of June 4.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

  • As of June 7, Taiwan has 11,491 cases and 286 deaths.
  • Taiwan has 11,298 cases and 260 deaths as of June 6.
  • Taiwan has 10,956 cases and 225 deaths as of June 5.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

  • Turkey has 5,287,980 cases and 48,164 deaths as of June 6.
  • As of June 5, Turkey has 5,282,594 cases and 48,068 deaths.
  • Turkey has 5,276,468 cases and 47,976 deaths as of June 4.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

  • The UAE has 583,071 cases and 1,699 deaths as of June 6.
  • As of June 5, the UAE has 581,197 cases and 1,696 deaths.
  • The UAE has 579,009 cases and 1,691 deaths as of June 4.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

  • Uzbekistan has 101,722 cases and 696 deaths as of June 6.
  • As of June 5, Uzbekistan has 101,436 cases and 696 deaths.
  • Uzbekistan has 101,198 cases and 695 deaths as of June 4.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

  • Yemen has 6,787 cases and 1,329 deaths as of June 6.
  • As of June 5, Yemen has 6,780 cases and 1,325 deaths.
  • Yemen has 6,773 cases and 1,325 deaths as of June 4.

 

About Us

ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in SingaporeHanoiHo Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, MilanConegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in MalaysiaBangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at asia@dezshira.com or visit our website at www.dezshira.com.

IN THIS ARTICLE

 

 

Другие новости